LLY compared with CORT: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

CORTCorcept Therapeutics Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

CORTCorcept Therapeutics Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

CORT2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±11.3%▼−3.31%×0.29

Q2 FY26—▲+27.29%—

= impliedLLY realized, solidCORT realized, hatchedOne scale, both sides: full bar = 28%× = |realized| ÷ impliedspan: LLY 267d · CORT 97dSource: market data

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

CORTCorcept Therapeutics Inc

72.35▼−8.67%· post 70.81

ClosedNov 5 '26

Mkt cap$7.8BRevenue$340MQ3 FY26Revenue$761MFY25

Compare

ClosedNov 5 '26

LLYELI Lilly & Co

CORTCorcept Therapeutics Inc

1,371.32▼−3.29%post 1,363.77

Price

72.35▼−8.67%post 70.81

$1.2T

Mkt cap

$7.8B

Q3 FY26$24.4B

Revenue

$340MQ3 FY26

FY25$65.2B

Revenue

$761MFY25

LLY1,371.32▼−3.29%vsCORT72.35▼−8.67%ClosedNov 5 '26